- Home
- BODI vs PEPG Comparison
BODI vs PEPG Comparison
Compare BODI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- PEPG
- Stock Information
- Founded
- BODI 1998
- PEPG 2018
- Country
- BODI United States
- PEPG United States
- Employees
- BODI N/A
- PEPG N/A
- Industry
- BODI Industrial Machinery/Components
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- PEPG Health Care
- Exchange
- BODI Nasdaq
- PEPG Nasdaq
- Market Cap
- BODI 40.1M
- PEPG 45.9M
- IPO Year
- BODI N/A
- PEPG 2022
- Fundamental
- Price
- BODI $6.80
- PEPG $1.89
- Analyst Decision
- BODI Buy
- PEPG Buy
- Analyst Count
- BODI 2
- PEPG 4
- Target Price
- BODI $10.00
- PEPG $7.25
- AVG Volume (30 Days)
- BODI 14.7K
- PEPG 539.9K
- Earning Date
- BODI 11-11-2025
- PEPG 11-06-2025
- Dividend Yield
- BODI N/A
- PEPG N/A
- EPS Growth
- BODI N/A
- PEPG N/A
- EPS
- BODI N/A
- PEPG N/A
- Revenue
- BODI $324,871,000.00
- PEPG N/A
- Revenue This Year
- BODI N/A
- PEPG N/A
- Revenue Next Year
- BODI N/A
- PEPG N/A
- P/E Ratio
- BODI N/A
- PEPG N/A
- Revenue Growth
- BODI N/A
- PEPG N/A
- 52 Week Low
- BODI $3.38
- PEPG $0.88
- 52 Week High
- BODI $8.71
- PEPG $10.06
- Technical
- Relative Strength Index (RSI)
- BODI 67.83
- PEPG 73.39
- Support Level
- BODI $5.30
- PEPG $1.35
- Resistance Level
- BODI $7.29
- PEPG $2.10
- Average True Range (ATR)
- BODI 0.47
- PEPG 0.18
- MACD
- BODI 0.10
- PEPG 0.07
- Stochastic Oscillator
- BODI 77.42
- PEPG 84.54
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.